BioAtla, Inc. (BCAB)
NASDAQ: BCAB · Real-Time Price · USD
0.3733
-0.0193 (-4.92%)
At close: Mar 28, 2025, 4:00 PM
0.3695
-0.0038 (-1.03%)
After-hours: Mar 28, 2025, 7:56 PM EDT
BioAtla Market Cap
BioAtla has a market cap or net worth of $21.66 million as of March 28, 2025. Its market cap has decreased by -82.31% in one year.
Market Cap
21.66M
Enterprise Value
-27.39M
1-Year Change
-82.31%
Ranking
Category
Stock Price
$0.37
Market Cap Chart
Since the IPO on December 16, 2020, BioAtla's market cap has decreased from $577.60M to $21.66M, a decrease of -96.25%. That is a compound annual growth rate of -53.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 21.66M | -36.86% |
| Dec 31, 2024 | 34.30M | -70.91% |
| Dec 29, 2023 | 117.92M | -69.81% |
| Dec 30, 2022 | 390.66M | -45.97% |
| Dec 31, 2021 | 723.09M | -36.84% |
| Dec 31, 2020 | 1.14B | 98.22% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 737.95B |
| UnitedHealth Group | 475.55B |
| Johnson & Johnson | 394.91B |
| AbbVie | 357.35B |
| Novo Nordisk | 308.71B |
| Abbott Laboratories | 228.51B |
| Merck & Co. | 225.45B |
| AstraZeneca | 225.00B |